SLC19A3 Gene Defects Sorting the Phenotype and Acronyms: Review

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Neuropediatrics

• Publication date

  2017-09-29

• Fields of study

  Medicine

• Identifiers
  DOI 10.1055/s-0037-1607191PMID 28962040
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Biotin-thiamine-responsive basal ganglia disease

  2018cited by this paper
• Biotin–thiamine–responsive basal ganglia disease: catastrophic consequences of delay in diagnosis and treatment

  2017cited by this paper
• Biotin thiamine responsive basal ganglia disease-A potentially treatable inborn error of metabolism.

  2016cited by this paper
• Free-thiamine is a potential biomarker of thiamine transporter-2 deficiency: a treatable cause of Leigh syndrome.

  2016cited by this paper
• New perspective in diagnostics of mitochondrial disorders: two years’ experience with whole-exome sequencing at a national paediatric centre

  2016cited by this paper
• A case report of biotin–thiamine-responsive basal ganglia disease in a Saudi child

  2016cited by this paper
• Teaching NeuroImages: MRI findings of biotin-responsive basal ganglia disease before and after treatment

  2016cited by this paper
• Biotin and Thiamine Responsive Basal Ganglia Disease--A vital differential diagnosis in infants with severe encephalopathy.

  2016cited by this paper
• Teaching NeuroImages: Biotin-responsive basal ganglia disease

  2016cited by this paper
• Novel SLC19A3 Promoter Deletion and Allelic Silencing in Biotin-Thiamine-Responsive Basal Ganglia Encephalopathy

  2016cited by this paper
• Depression in adult patients with biotin responsive basal ganglia disease.

  2016cited by this paper
• Treatment of biotin-responsive basal ganglia disease: Open comparative study between the combination of biotin plus thiamine versus thiamine alone.

  2015cited by this paper
• Biotin-responsive basal ganglia disease: a case diagnosed by whole exome sequencing

  2015cited by this paper
• Thiamine transporter-2 deficiency: outcome and treatment monitoring

  2014cited by this paper
• Whole exome sequencing reveals compound heterozygous mutations in SLC19A3 causing biotin-thiamine responsive basal ganglia disease

  2014cited by this paper
• Biotin-Responsive Basal Ganglia Disease: Neuroimaging Features before and after Treatment

  2014cited by this paper
• Stress‐Induced Upregulation of SLC19A3 is Impaired in Biotin‐Thiamine‐Responsive Basal Ganglia Disease

  2014cited by this paper
• Infantile Leigh-like syndrome caused by SLC19A3 mutations is a treatable disease.

  2014cited by this paper
• Defects of thiamine transport and metabolism

  2014cited by this paper
• Reply: Infantile Leigh-like syndrome caused by SLC19A3 mutations is a treatable disease.

  2014cited by this paper
• Exome sequencing reveals mutated SLC19A3 in patients withan early-infantile, lethal, encephalopathy

  2013cited by this paper
• Biotin-responsive basal ganglia disease should be renamed biotin-thiamine-responsive basal ganglia disease: a retrospective review of the clinical, radiological and molecular findings of 18 new cases

  2013cited by this paper
• Bilateral external ophthalmoplegia in biotin-responsive basal ganglia disease.

  2013cited by this paper
• Biotin-responsive Basal Ganglia disease: a treatable differential diagnosis of leigh syndrome.

  2013cited by this paper
• Treatable Leigh-like encephalopathy presenting in adolescence

  2013cited by this paper
• Reversible Lactic Acidosis in a Newborn With Thiamine Transporter-2 Deficiency

  2013cited by this paper
• Exome sequencing reveals a novel Moroccan founder mutation in SLC19A3 as a new cause of early-childhood fatal Leigh syndrome.

  2013cited by this paper
• Biotin-responsive basal ganglia disease in a 10-year-old German girl without SLC19A3 gene mutation

  2013cited by this paper
• Biotin-responsive basal ganglia disease revisited

  2013cited by this paper
• Reversible generalized dystonia and encephalopathy from thiamine transporter 2 deficiency

  2012cited by this paper
• A wide spectrum of clinical and brain MRI findings in patients with SLC19A3 mutations

  2010cited by this paper
• Thiamine Status in Humans and Content of Phosphorylated Thiamine Derivatives in Biopsies and Cultured Cells

  2010cited by this paper
• Biotin-responsive basal ganglia disease in ethnic Europeans with novel SLC19A3 mutations.

  2010cited by this paper
• Biotin-Responsive Basal Ganglia Disease: A Treatable and Reversible Neurological Disorder of Childhood

  2009cited by this paper
• Mutations in a thiamine-transporter gene and Wernicke's-like encephalopathy.

  2009cited by this paper
• Biotin-Responsive Basal Ganglia Disease: Case Report and Review of the Literature

  2008cited by this paper
• The evidence that the DNC (SLC25A19) is not the mitochondrial deoxyribonucleotide carrier.

  2008cited by this paper
• Biotin responsive limb weakness.

  2007cited by this paper
• Biotin-responsive basal ganglia disease-linked mutations inhibit thiamine transport via hTHTR2: biotin is not a substrate for hTHTR2.

  2006cited by this paper
• Biotin-responsive basal ganglia disease maps to 2q36.3 and is due to mutations in SLC19A3.

  2005cited by this paper
• Biotin deficiency reduces expression of SLC19A3, a potential biotin transporter, in leukocytes from human blood.

  2005cited by this paper
• SLC19: the folate/thiamine transporter family

  2004cited by this paper
• Regulation of gene expression by biotin (review).

  2003cited by this paper
• Mutations in a new gene encoding a thiamine transporter cause thiamine-responsive megaloblastic anaemia syndrome

  1999cited by this paper
• Biotin-responsive basal ganglia disease: a novel entity.

  1998cited by this paper

• BIOCHEMICAL AND MEDICAL ASPECTS OF VITAMIN B1 RESEARCH.

  2025cites this paper
• Genetic and metabolic diagnostic profile of children presented with spastic paraplegia/diplegia

  2025cites this paper
• Biotin-Thiamine-Responsive Basal Ganglia Disease: Clinical Features, Treatment Response and Predictive Factors in a Cohort in a Tertiary Hospital

  2025cites this paper
• Severe Acute Motor Exacerbations (SAME) across Metabolic, Developmental and Genetic Disorders

  2024cites this paper
• The Impacts of Slc19a3 Deletion and Intestinal SLC19A3 Insertion on Thiamine Distribution and Brain Metabolism in the Mouse

  2023cites this paper
• Biotin-thiamine responsive basal ganglia disease: a retrospective review of the clinical, radiological and molecular findings of cases in Kuwait with novel variants

  2023cites this paper
• An unusually mild case of biotin-thiamine-responsive basal ganglia disease

  2023influential citation
• The pathogenicity of variant c.597dup in SLC19A3 and treatability of its phenotype remain unconfirmed

  2023cites this paper
• Experimental pharmacology: Targeting metabolic pathways.

  2023cites this paper
• Mechanisms underlying phenotypic variation in neurogenetic disorders

  2023cites this paper
• Next-generation sequencing of Tunisian Leigh syndrome patients reveals novel variations: impact for diagnosis and treatment

  2022cites this paper
• Case Report: Motor and Sensory Development of a Case Followed with Suspicion of Neonatal Thiamine Metabolism Dysfunction Syndrome

  2022cites this paper
• Identification of the amino acid residues involved in the species-dependent differences in the pyridoxine transport function of SLC19A3

  2022cites this paper
• Biotin-Responsive Basal Ganglia Disease: Treatable Metabolic Disorder with SLC19A3 Mutation Presenting as Rapidly Progressive Dementia

  2022cites this paper
• Thiamine Disorders

  2022cites this paper
• Beyond the caudate nucleus: Early atypical neuroimaging findings in biotin-thiamine- responsive basal ganglia disease.

  2022cites this paper
• SLC gene mutations and pediatric neurological disorders: diverse clinical phenotypes in a Saudi Arabian population

  2021cites this paper
• Biotin-Thiamine-Responsive Basal Ganglia Disease in Children: A Treatable Neurometabolic Disorder

  2021cites this paper
• Report of the Largest Chinese Cohort With SLC19A3 Gene Defect and Literature Review

  2021cites this paper
• Vitamin responsive conditions in pediatric neurology

  2021cites this paper
• Early Infantile Thiamine Transporter-2 Deficiency with Epileptic Spasms—A Phenotypic Spectrum with a Novel Mutation

  2021cites this paper
• Early treatment of biotin–thiamine–responsive basal ganglia disease improves the prognosis

  2021influential citation
• ACTH for epileptic spasms in Leigh syndrome with SLC19A3 mutation can induce status dystonicus.

  2021cites this paper
• Treatable Inherited Movement Disorders in Children: Spotlight on Clinical and Biochemical Features

  2020cites this paper
• Thiamine

  2020cites this paper
• Subcortical neural generators of the envelope-following response in sleeping children: A transfer function analysis.

  2020cites this paper
• Inherited biotin-responsive disorders

  2020cites this paper
• Unusual case of biotin-thiamine responsive encephalopathy without basal ganglia involvement

  2020cites this paper
• The Relevance of Thiamine Evaluation in a Practical Setting

  2020cites this paper
• Single gene, two diseases, and multiple clinical presentations: Biotin-thiamine-responsive basal ganglia disease.

  2020cites this paper
• Genomic profiling of 553 uncharacterized neurodevelopment patients reveals a high proportion of recessive pathogenic variant carriers in an outbred population

  2019cites this paper
• Targeted SLC19A3 gene sequencing of 3000 Saudi newborn: a pilot study toward newborn screening

  2019cites this paper
• Kurzschluss im Nervensystem: Ausgewählte Umweltfaktoren und Mikronährstoffe bei Multipler Sklerose

  2019cites this paper
• [Paroxysmal crying and motor regression for more than two months in an infant].

  2019cites this paper
• Comprehensive genetic analysis by whole exome sequencing in 352 Korean pediatric patients with unknown neurodevelopmental disorders

  2018cites this paper
• SLC19A3 related disorder: Treatment implication and clinical outcome of 2 new patients.

  2017cites this paper